What percentage of individuals with poorly controlled diabetes develop diabetic foot ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Foot Ulcer Incidence in Uncontrolled Diabetes

Approximately 19-34% of people with diabetes will develop a diabetic foot ulcer during their lifetime, with a yearly incidence of approximately 2%. 1, 2, 3

Lifetime and Annual Risk

  • The lifetime incidence rate of diabetes-related foot ulceration ranges from 19% to 34% across all people with diabetes 1, 2, 3, 4
  • The yearly (annual) incidence is approximately 2% in the general diabetic population 1
  • Some regional variations exist, with the prevalence of active foot ulcers estimated at 6.3% globally, though rates vary from 5.5% in Asia, Europe and Africa to 13% in North America 1

The Critical Role of "Uncontrolled" Diabetes

While your question specifically asks about "uncontrolled" diabetes, the evidence shows that all people with diabetes are at risk, but the degree of risk stratification depends on specific complications rather than glycemic control alone:

  • Peripheral neuropathy is present in 78% of patients who develop diabetic foot ulcers, making it the dominant risk factor 5
  • Longitudinal changes in fasting blood sugar are significantly associated with increased risk of diabetic foot ulcers (AHR = 6.35) 6
  • The pathophysiologic triad underlying ulcer development consists of neuropathy, vascular insufficiency, and secondary infection following trauma—all consequences of prolonged poor glycemic control 7, 3

Risk Stratification: Who Actually Develops Ulcers

The International Working Group on the Diabetic Foot (IWGDF) categorizes patients into risk groups that predict ulceration probability 1, 2:

  • Category 0 (Very Low Risk): No loss of protective sensation, no peripheral artery disease—annual screening sufficient 1
  • Category 1 (Low Risk): Loss of protective sensation OR peripheral artery disease—screening every 6-12 months 1
  • Category 2 (Moderate Risk): Loss of protective sensation PLUS peripheral artery disease, OR loss of protective sensation plus foot deformity—screening every 3-6 months 1
  • Category 3 (High Risk): Loss of protective sensation or peripheral artery disease PLUS history of previous ulceration or amputation—screening every 1-3 months 1, 5

More than one-third (33%) of diabetic patients fall into high-risk categories (IWGDF groups 2 and 3) 8

Recurrence Rates: The Devastating Reality

After successful healing, the risk of developing another ulcer is alarmingly high:

  • 40% recurrence rate within 1 year after healing 1, 4
  • 65% recurrence rate within 3 years after healing 1, 2
  • 65% recurrence rate within 5 years after healing 4

This means that once a person with diabetes develops their first ulcer, they have entered a high-risk category where nearly half will develop another ulcer within 12 months.

Key Risk Factors That Drive These Numbers

The specific complications of uncontrolled diabetes that lead to ulceration include:

  • Loss of protective sensation (neuropathy): Present in 42-78% of patients who develop ulcers 5, 8
  • Peripheral arterial disease: Present in up to 50% of diabetic foot ulcer patients 2, 5
  • Foot deformities: Present in 46% of diabetic patients and significantly associated with ulceration 8
  • Previous foot ulceration or amputation: The single strongest predictor of future ulceration 1, 2

Common Pitfalls in Interpreting These Statistics

  • Do not assume that "uncontrolled diabetes" alone predicts ulceration—the presence of neuropathy and peripheral arterial disease are the actual mechanistic drivers 2, 7
  • Do not overlook that approximately 15% of individuals with diabetes will eventually develop diabetic foot ulcers when considering all diabetes patients, not just those with poor control 7
  • The incidence of 12.1% was found in one Ethiopian cohort, which may reflect regional differences in healthcare access and footwear 6
  • Approximately 50-60% of ulcers become infected, and about 20% of moderate to severe infections lead to amputation 4

Mortality Context

  • The 5-year mortality rate for individuals with a diabetic foot ulcer is approximately 30%, exceeding 70% for those with major amputation 4
  • Mortality rate is 231 deaths per 1000 person-years in people with diabetic foot ulcers, compared with 182 deaths per 1000 person-years in people with diabetes without foot ulcers 4

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Foot Ulcer Pathophysiology and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5
Guideline

Risk of Additional Diabetic Complications in Patients with Diabetic Foot

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the statistics and management strategies for diabetic foot globally and in specific locations?
What is the most appropriate management for a 50-year-old diabetic man with a 5-year history of an unhealed foot ulcer on the dorsal aspect of the first toe, confirmed as pseudoepitheliomatous hyperplasia on biopsy?
What is the next best step in treatment of a patient with a diabetic foot ulcer and an Ankle-Brachial Pressure Index (ABPI) of 0.7?
What is the most critical test to perform on a diabetic patient with a well-demarcated plantar foot ulcer, nearly diminished sensation, and inability to perceive touch?
What is the most important diagnostic test for a diabetic patient with a well-demarcated plantar foot ulcer, nearly diminished sensation, and signs of healing with central erythema?
In a septic shock patient with worsening hypotension despite high‑dose norepinephrine and moderate‑dose dopamine and dobutamine, how should vasopressor and inotropic therapy be adjusted?
What rehabilitation program is recommended for a patient with radial nerve palsy who has intact volar (flexor) muscles to preserve wrist and finger extension and prevent contracture?
What is the appropriate oral ambroxol dosage for pediatric patients based on age and weight?
What is the appropriate evaluation and management for a patient presenting with right lower quadrant abdominal pain, fever, nausea, and mild diarrhoea suggestive of mesenteric adenitis?
What are the recommended dosing regimens of terbutaline for acute bronchospasm in adults and children and for tocolysis in pregnant women, and what are its contraindications and common adverse effects?
How should a 30-year-old woman at 21 weeks gestation with a brief, reversible neurological event be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question